US Edition
GE HealthCare CleaRecon DL for CBCT Imaging Launched in United States and Europe - Endovascular Today
Summary by Endovascular Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
GE HealthCare CleaRecon DL for CBCT Imaging Launched in United States and Europe - Endovascular Today
May 21, 2025—GE HealthCare recently announced the launch of CleaRecon DL in the United States and European Union. The technology, which recently received FDA 510(k) clearance and CE Mark approval, will be available for use on the company’s Allia platform of interventional image-guided systems. According to GE HealthCare, CleaRecon DL is powered by a deep-learning algorithm to improve the quality of cone-beam CT (CBCT) images. The artificial inte…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
